1 |
Sakamoto K, Imanishi Y, Tomita T, et al. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage Ⅰ/Ⅱ oral tongue squamous cell carcinoma after partial glossectomy[J]. Ann Surg Oncol, 2012, 19(2): 612-619.
|
2 |
Karatas OF, Oner M, Abay A, et al. MicroRNAs in human tongue squamous cell carcinoma: from pathogenesis to therapeutic implications[J]. Oral Oncol, 2017, 67: 124-130.
|
3 |
Sun L, Liang J, Wang Q, et al. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion[J]. Cell Prolif, 2016, 49(5): 628-635.
|
4 |
Liu C, Tong Z, Tan J, et al. MicroRNA-21-5p targeting PDCD4 suppresses apoptosis via regulating the PI3K/AKT/FOXO1 signaling pathway in tongue squamous cell carcinoma[J]. Exp Ther Med, 2019, 18(5): 3543-3551.
|
5 |
Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue‒clinicopathologic features affecting outcome[J]. Cancer, 2012, 118(1): 101-111.
|
6 |
Wang B, Zhang S, Yue K, et al. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases[J]. Chin J Cancer, 2013, 32(11): 614-618.
|
7 |
Flaus A, Martin DM, Barton GJ, et al. Identification of multiple distinct Snf2 subfamilies with conserved structural motifs[J]. Nucleic Acids Res, 2006, 34(10): 2887-2905.
|
8 |
Eisen JA, Sweder KS, Hanawalt PC. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions[J]. Nucleic Acids Res, 1995, 23(14): 2715-2723.
|
9 |
Hyeon J, Ahn S, Park CK. CHD1L is a marker for poor prognosis of hepatocellular carcinoma after surgical resection[J]. Korean J Pathol, 2013, 47(1): 9-15.
|
10 |
Li F, Zhang Z, Wang P, et al. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway[J]. Life Sci, 2019, 232: 116679.
|
11 |
Li Y, He LR, Gao Y, et al. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer[J]. Cell Death Dis, 2019, 10(2): 99.
|
12 |
王照岩, 杨志一, 林祥博, 等. miR-504靶向CHD1L抑制乳腺癌细胞侵袭的分子机制[J]. 临床与实验病理学杂志, 2018, 34(12): 1302-1307.
|
|
Wang ZY, Yang ZY, Lin XB, et al. The molecular mechanism of miR-504 targeting CHD1L inhibiting the invasion of breast cancer cells[J]. J Clin Exp Pathol, 2018, 34(12): 1302-1307.
|
13 |
Yin K, Zhang Y, Zhang S, et al. Using weighted gene co-expression network analysis to identify key modules and hub genes in tongue squamous cell carcinoma[J]. Medicine (Baltimore), 2019, 98(37): e17100.
|
14 |
Mu QJ, Li HL, Yao Y, et al. Chromodomain helicase/ATPase DNA-binding protein 1-like gene (CHD1L) expression and implications for invasion and metastasis of breast cancer[J]. PLoS One, 2015, 10(11): e0143030.
|
15 |
Belcher R, Hayes K, Fedewa S, et al. Current treatment of head and neck squamous cell cancer[J]. J Surg Oncol, 2014, 110(5): 551-574.
|
16 |
Su CC, Lee KI, Chen MK, et al. Cantharidin induced oral squamous cell carcinoma cell apoptosis via the JNK-regulated mitochondria and endoplasmic reticulum stress-related signaling pathways[J]. PLoS One, 2016, 11(12): e0168095.
|
17 |
Ho AS, Kim S, Tighiouart M, et al. Metastatic lymph node burden and survival in oral cavity cancer[J]. J Clin Oncol, 2017, 35(31): 3601-3609.
|
18 |
Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis[J]. Cancer Res, 2009, 69(18): 7135-7139.
|
19 |
Lyons JG, Lobo E, Martorana AM, et al. Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions[J]. Clin Exp Metastasis, 2008, 25(6): 665-677.
|
20 |
Jang TJ. Epithelial to mesenchymal transition in cutaneous squamous cell carcinoma is correlated with COX-2 expression but not with the presence of stromal macrophages or CD10-expressing cells[J]. Virchows Arch, 2012, 460(5): 481-487.
|
21 |
Hodorogea A, Calinescu A, Antohe M, et al. Epithelial-mesenchymal transition in skin cancers: a review[J]. Anal Cell Pathol (Amst), 2019, 2019: 3851576.
|
22 |
Wang X, Guo H, Yao B, et al. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer[J]. Oncol Rep, 2017, 37(5): 2720-2726.
|
23 |
Chen L, Chan TH, Yuan YF, et al. CHD1L promotes hepatocellular carcinoma progression and metastasis in mi-ce and is associated with these processes in human patients[J]. J Clin Invest, 2010, 120(4): 1178-1191.
|
24 |
Liu C, Fu X, Zhong Z, et al. CHD1L expression increases tumor progression and acts as a predictive biomarker for poor prognosis in pancreatic cancer[J]. Dig Dis Sci, 2017, 62(9): 2376-2385.
|